Science Explorer Interactive view Map
Company · Guadalajara · Mexico

Boehringer Ingelheim (Mexico)

bi-vetmedica.com.mxROR OpenAlex
Research works
30
▼ 86% vs 2013–17
Citations
178
6.0 per fractional work
Top-10% rate
6.9%
record average 16.5%
Open access
35%
world 28%

Not ranked overall: Boehringer Ingelheim (Mexico) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.88× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.07× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 8.12× its world share, 0 worksImmunology and Micro…Neuroscience: 0.02× its world share, 0 worksNeuroscienceMathematics: 0.06× its world share, 0 worksMathematicsMedicine: 3.25× its world share, 4 worksMedicineNursing: 15.93× its world share, 0 worksNursingVeterinary: 13.68× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 0.02× its world share, 0 worksEconomics, Econometr…Psychology: 0.05× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 15.9×. Every wedge is a field page.

Who are the top researchers at Boehringer Ingelheim (Mexico)?

Ranked on the composite score, Santiago Herrán lead among researchers whose main affiliation is Boehringer Ingelheim (Mexico).

  1. 1 Santiago Herrán Mexico · #1,367,144 worldwide 4 citations · 18 works
All ranked researchers at Boehringer Ingelheim (Mexico)

Which keywords describe research at Boehringer Ingelheim (Mexico)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Clinical Trials, Botulinum Toxin, Neurotoxins, Treatment, Cost-effectiveness Analysis, Drug Development Costs and Generic Drugs.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology4▲ 3.5×17 topics
  2. Clinical Trials2▲ 11×4 topics
  3. Quality of Life2▲ 5.1×2 topics
  4. Treatment2▲ 5.5×2 topics
  5. Botulinum Toxin2▲ 98×1 topic
  6. Neurotoxins2▲ 134×1 topic
  7. Cost-effectiveness Analysis2▲ 77×1 topic
  8. Drug Development Costs2▲ 236×1 topic
  9. Generic Drugs2▲ 236×1 topic
  10. Health Utility Measures2▲ 77×1 topic
  11. Antimicrobial Resistance2▲ 22×4 topics
  12. Cardiovascular Disease2▲ 5.1×4 topics
  13. Global Burden2▲ 11×3 topics
  14. Pathogenesis2▲ 9.3×5 topics
  15. Vaccine Development2▲ 17×4 topics
  16. ALK Inhibitors2▲ 92×1 topic
  17. EGFR Mutations2▲ 92×1 topic
  18. Gut Microbiota2▲ 15×4 topics
  19. Host-Pathogen Interactions2▲ 47×2 topics
  20. Targeted Therapy2▲ 24×2 topics
  21. Genomic Sequencing1▲ 33×2 topics
  22. Guidelines1▲ 10×2 topics
  23. Immunotherapy1▲ 7.0×3 topics
  24. Public Health1▲ 3.6×5 topics
  25. Economic Impact1▲ 13×2 topics
  26. Probiotics1▲ 17×3 topics
  27. Respiratory1▲ 44×2 topics
  28. Type 1 Diabetes1▲ 46×2 topics
  29. Fibrosis1▲ 21×2 topics
  30. Mycoplasma1▲ 131×1 topic
  31. Pasteurella1▲ 131×1 topic
  32. Risk Factors1▲ 3.8×3 topics
  33. Idiopathic Pulmonary Fibrosis1▲ 93×1 topic
  34. Immunomodulation1▲ 25×3 topics
  35. Interstitial Lung Disease1▲ 67×1 topic
  36. Ischemic Stroke1▲ 27×2 topics
  37. Neuroprotection1▲ 9.6×2 topics
  38. Acute Coronary Syndromes1▲ 83×1 topic
  39. Antibiotic Resistance1▲ 8.3×3 topics
  40. Myocardial Infarction1▲ 13×1 topic

Which research topics does Boehringer Ingelheim (Mexico) publish most on?

By volume in 2022–2025: Botulinum Toxin and Related Neurological Disorders, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Parasitic Diseases Research and Treatment and Microbial Metabolites in Food Biotechnology.

Botulinum Toxin and Rela…2Botulinum Toxin and Related Neurological Disorders: 2 fractional worksInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 1 fractional worksParasitic Diseases Research and Treatment: 0 fractional worksMicrobial Metabolites in Food Biotechnology: 0 fractional worksProbiotics and Fermented…0Probiotics and Fermented Foods: 0 fractional worksVector-borne infectious diseases: 0 fractional worksGut microbiota and health: 0 fractional worksParasites and Host Interactions: 0 fractional worksMosquito-borne diseases and control: 0 fractional worksViral gastroenteritis research and epidemiology: 0 fractional works
NeurologyPulmonary and Respiratory MedicineInfectious DiseasesNutrition and Dietetics4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Botulinum Toxin and Related Neurological Disorders Neurology 2 works
  2. 2 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 1 works
  3. 3 Parasitic Diseases Research and Treatment Infectious Diseases 0 works
  4. 4 Microbial Metabolites in Food Biotechnology Nutrition and Dietetics 0 works
  5. 5 Probiotics and Fermented Foods Food Science 0 works
  6. 6 Vector-borne infectious diseases Parasitology 0 works
  7. 7 Gut microbiota and health Molecular Biology 0 works
  8. 8 Parasites and Host Interactions Parasitology 0 works
  9. 9 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 0 works
  10. 10 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.9%not open65.1%

World: 28% of research is openly available.

with international co-authors37.1%domestic only62.9%

World: 19% is written across borders.

How has Boehringer Ingelheim (Mexico)'s research output changed?

Output in 2018–2022 was 86% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Guadalajara

All research institutions in Guadalajara

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.